For: | Peng XH, Ren XN, Chen LX, Shi BS, Xu CH, Fang Z, Liu X, Chen JL, Zhang XN, Hu YW, Zhou XH. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice. World J Gastroenterol 2015; 21(12): 3527-3536 [PMID: 25834317 DOI: 10.3748/wjg.v21.i12.3527] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3527.htm |
Number | Citing Articles |
1 |
Jau-Hau Horng, Chang-Ru Wu, Pei-Jer Chen. Hepatitis B Virus and Liver Disease. 2018; : 343 doi: 10.1007/978-981-10-4843-2_17
|
2 |
Marketa Pimkova Polidarova, Lenka Vanekova, Petra Brehova, Milan Dejmek, Zdenek Vavrina, Gabriel Birkus, Andrea Brazdova. Synthetic Stimulator of Interferon Genes (STING) Agonists Induce a Cytokine-Mediated Anti-Hepatitis B Virus Response in Nonparenchymal Liver Cells. ACS Infectious Diseases 2023; 9(1): 23 doi: 10.1021/acsinfecdis.2c00424
|
3 |
L VANEKOVA, M POLIDAROVA, V CHARVAT, Z VAVRINA, V VEVERKA, G BIRKUS, A BRAZDOVA. Development and Characterization of a Chronic Hepatitis B Murine Model With a Mutation in the START Codon of an HBV Polymerase. Physiological Research 2023; 72(1): 37 doi: 10.33549/physiolres.934979
|
4 |
Benjamin J. Burwitz, Zhongmin Zhou, Wenhui Li. Animal models for the study of human hepatitis B and D virus infection: New insights and progress. Antiviral Research 2020; 182: 104898 doi: 10.1016/j.antiviral.2020.104898
|
5 |
Yanqin Du, Ruth Broering, Xiaoran Li, Xiaoyong Zhang, Jia Liu, Dongliang Yang, Mengji Lu. In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.766534
|
6 |
Jie Yu, Zhongliang Shen, Shiqi Chen, Hongyan Liu, Zunguo Du, Richeng Mao, Jinyu Wang, Yongmei Zhang, Haoxiang Zhu, Sisi Yang, Jing Li, Jingwen Wu, Minhui Dong, Mengqi Zhu, Yuxian Huang, Jianhua Li, Zhenghong Yuan, Youhua Xie, Mengji Lu, Jiming Zhang. Inhibition of HBV replication by EVA1A via enhancing cellular degradation of HBV components and its potential therapeutic application. Antiviral Research 2023; 216: 105643 doi: 10.1016/j.antiviral.2023.105643
|
7 |
Lena Allweiss, Maura Dandri. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. Journal of Hepatology 2016; 64(1): S17 doi: 10.1016/j.jhep.2016.02.012
|
8 |
Jieliang Chen, Min Wu, Kuancheng Liu, Wen Zhang, Yaming Li, Xiaohui Zhou, Lu Bai, Zhenghong Yuan. New insights into hepatitis B virus biology and implications for novel antiviral strategies. National Science Review 2015; 2(3): 296 doi: 10.1093/nsr/nwv044
|
9 |
Niloofar Khoshdel-Rad, Ensieh Zahmatkesh, Polina Bikmulina, Maria Peshkova, Nastasia Kosheleva, Evgeny A. Bezrukov, Roman B. Sukhanov, Anna Solovieva, Anastasia Shpichka, Peter Timashev, Massoud Vosough. Modeling Hepatotropic Viral Infections: Cells vs. Animals. Cells 2021; 10(7): 1726 doi: 10.3390/cells10071726
|
10 |
Xiaonan Zhang, Xiaomeng Wang, Min Wu, Reena Ghildyal, Zhenghong Yuan. Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.715450
|
11 |
Amy P Chiu, Barbara R Tschida, Lilian H Lo, Branden S Moriarity, Dewi K Rowlands, David A Largaespada, Vincent W Keng. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12157-12170 doi: 10.3748/wjg.v21.i42.12157
|
12 |
Feng Li, Zhuo Wang, Fengyu Hu, Lishan Su. Hepatitis B Virus Infection. Advances in Experimental Medicine and Biology 2020; 1179: 109 doi: 10.1007/978-981-13-9151-4_5
|
13 |
Rui Zhang, Zhe Lu, Yachen Xu, Qian Peng, Man Xiao, Shenggang Sang, Washim Khan. Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/5625222
|
14 |
Yu Liu, Miaoxian Zhao, Mingxing Gong, Ying Xu, Cantao Xie, Haohui Deng, Xueying Li, Hongkai Wu, Zhanhui Wang. Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus. Antiviral Research 2018; 152: 58 doi: 10.1016/j.antiviral.2018.02.011
|
15 |
Aleksey M. Nagornykh, Marina A. Tyumentseva, Aleksandr I. Tyumentsev, Vasiliy G. Akimkin, Md. Golzar Hossain. Protocol for chronic hepatitis B virus infection mouse model development by patient-derived orthotopic xenografts. PLOS ONE 2022; 17(2): e0264266 doi: 10.1371/journal.pone.0264266
|
16 |
Antonio Bertoletti, Julie Lucifora, Fabien Zoulim. Zakim and Boyer's Hepatology. 2018; : 464 doi: 10.1016/B978-0-323-37591-7.00031-8
|
17 |
Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li. Clinical impact and mechanisms in hepatitis B virus infection concurrent with non-alcoholic fatty liver disease. Chinese Medical Journal 2022; doi: 10.1097/CM9.0000000000002310
|
18 |
|
19 |
Caorui Lin, Linjie Luo, Zhen Xun, Chenggong Zhu, Ying Huang, Yuchen Ye, Jiawei Zhang, Tianbin Chen, Songhang Wu, Fuguo Zhan, Bin Yang, Can Liu, Ning Ran, Qishui Ou. Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection. Gut 2024; 73(2): 338 doi: 10.1136/gutjnl-2023-330389
|